| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.084 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |